Correlation Between 23Andme Holding and Disc Medicine
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Disc Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Disc Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Disc Medicine, you can compare the effects of market volatilities on 23Andme Holding and Disc Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Disc Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Disc Medicine.
Diversification Opportunities for 23Andme Holding and Disc Medicine
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between 23Andme and Disc is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Disc Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Disc Medicine and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Disc Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Disc Medicine has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Disc Medicine go up and down completely randomly.
Pair Corralation between 23Andme Holding and Disc Medicine
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Disc Medicine. In addition to that, 23Andme Holding is 1.16 times more volatile than Disc Medicine. It trades about -0.08 of its total potential returns per unit of risk. Disc Medicine is currently generating about 0.04 per unit of volatility. If you would invest 4,950 in Disc Medicine on August 29, 2024 and sell it today you would earn a total of 1,315 from holding Disc Medicine or generate 26.57% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
23Andme Holding Co vs. Disc Medicine
Performance |
Timeline |
23Andme Holding |
Disc Medicine |
23Andme Holding and Disc Medicine Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 23Andme Holding and Disc Medicine
The main advantage of trading using opposite 23Andme Holding and Disc Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Disc Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Disc Medicine will offset losses from the drop in Disc Medicine's long position.23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
Disc Medicine vs. Anebulo Pharmaceuticals | Disc Medicine vs. Adagene | Disc Medicine vs. Acrivon Therapeutics, Common | Disc Medicine vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Correlations Find global opportunities by holding instruments from different markets |